Immunochromatographic analyzer for Mycoplasma pneumoniae detection
AssigneeTanaka Kikinzoku Kogyo K.K.
InventorsKeita Suzuki, Hisahiko Iwamoto
Life of this patent
Estimating the term…
Abstract
The present invention is intended to provide an immunochromatographic analyzer that enables a quick and easy, high-sensitivity detection of Mycoplasma pneumoniae, and thus more reliable and faster diagnosis of mycoplasma pneumonia. The immunochromatographic analyzer according to the present invention is for detecting Mycoplasma pneumoniae, and includes a sample adding section, a label-substance retaining section, a chromatographic medium section having a detection section, and an absorbing section. The label-substance retaining section and the detection section contain an antibody that strongly recognizes domain III of P30 protein of Mycoplasma pneumoniae consisting of the amino acid sequence of SEQ ID NO: 2.
Claims4
An immunochromatographic kit comprising:
- an immunochromatographic analyzer for detecting Mycoplasma pneumoniae and an analyte diluting solution for diluting and developing an analyte, wherein the immunochromatographic analyzer comprises:
- a sample adding section;
- a label-substance retaining section;
- a chromatographic medium section having a detection section;
- and
- an absorbing section,
- wherein the label-substance retaining section and the detection section contain an antibody that recognizes the amino acid sequence of SEQ ID NO:
- 3 in domain III of the P30 protein of Mycoplasma pneumoniae consisting of the amino acid sequence of SEQ ID NO:
- 2, and
- wherein the content of the antibody in the label-substance retaining section is 0.06 to 0.25 μg/device, and the analyte diluting solution contains a non-ionic surfactant having a hydrophilic-lipophilic balance value of 13 to 17.
A method for detecting Mycoplasma pneumoniae in an analyte using an immunochromatographic analyzer that includes a sample adding section, a label-substance retaining section, a chromatographic medium section having a detection section and an absorbing section,
- the method comprising the steps of:
- (1) adding to the sample adding section an analyte-containing solution prepared by diluting the analyte with an analyte diluting solution;
- (2) recognizing Mycoplasma pneumoniae with an antibody (hereinafter, “antibody P30(A)”) that is retained in the label-substance retaining section, and that recognizes the amino acid sequence of SEQ ID NO:
- 3 in domain III of the P30 protein of Mycoplasma pneumoniae consisting of the amino acid sequence of SEQ ID NO:
- 2;
- (3) developing the analyte and the antibody P30(A) as a mobile phase through the chromatographic medium section;
- and
- (4) detecting the Mycoplasma pneumoniae in the mobile phase developed, using the antibody P30(A) contained in the detection section.
Dependencies are inferred from the claim text.